GlassScriptPhysician profile
Brian R Cronson
NPI 1558597385
$111,202.66
in general payments reported to CMS, 2019-2025
27 companies · $47K in 2025
The $47K reported for 2025 was more than what 98% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $314 · 2020: $290 · 2021: $287 · 2022: $6,307 · 2023: $40K · 2024: $17K · 2025: $47K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $102K · Food and Beverage: $1,513.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $102,492.33 |
| Food and Beverage | $1,513.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verathon INC. | $108,502.33 | 2022-2025 | Npd Clinical Study, Bladderscanner |
| Procept Biorobotics Corporation | $567.84 | 2021-2025 | |
| Janssen Biotech, INC. | $449.80 | 2019-2025 | Erleada |
| Sumitomo Pharma America, INC. | $183.19 | 2023-2025 | Gemtesa, Orgovyx |
| Axonics, INC. | $182.75 | 2021-2024 | Axonics, Bulkamid |
| Urogen Pharma, INC. | $166.13 | 2022-2025 | Jelmyto |
| Astellas Pharma US INC | $130.55 | 2019-2021 | |
| Abbvie INC. | $114.01 | 2019-2025 | |
| Teleflex LLC | $107.99 | 2023-2024 | Urolift |
| Boston Scientific Corporation | $69.85 | 2019-2023 | Spaceoar Vue System - 10ml |
| Dendreon Pharmaceuticals LLC | $68.37 | 2021-2023 | Provenge |
| Laborie Medical Technologies Corp. | $67.96 | 2022-2023 | |
| Endo Pharmaceuticals INC. | $62.98 | 2019-2023 | Xiaflex |
| Olympus America INC. | $61.63 | 2024 | Itind System |
| Travere Therapeutics, INC. | $60.95 | 2019-2020 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acerus Pharmaceuticals Corporation | $52.91 | 2021 | |
| Neotract INC. | $45.46 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $43.46 | 2020-2025 | |
| Antares Pharma, INC. | $38.42 | 2019-2025 | Xyosted |
| Conmed Corporation | $38.10 | 2025 | Airseal |
| Blue Earth Diagnostics | $37.96 | 2024 | |
| Calyxo, INC. | $37.94 | 2025 | Cvac Aspiration System |
| Tolmar, INC. | $33.40 | 2025 | Eligard |
| Coloplast Corp | $26.58 | 2019-2020 | |
| Metuchen Pharmaceuticals | $21.15 | 2019 | |
| Cycle Pharmaceuticals INC | $16.63 | 2025 | Venxxiva |
| Cook Medical LLC | $14.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Cronson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.